Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 90 entries
Sorted by: Best Match Show Resources per page
Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease.

Fluids and barriers of the CNS

Patton SM, Cho YW, Clardy TW, Allen RP, Earley CJ, Connor JR.
PMID: 23758918
Fluids Barriers CNS. 2013 Jun 07;10(1):20. doi: 10.1186/2045-8118-10-20.

BACKGROUND: Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED) is a sensorimotor disorder that causes patients to experience overwhelming and distressing sensations in the legs compelling the patient to move their legs to provide relief. The purpose of this study was to...

Cite
Patton SM, Cho YW, Clardy TW, et al. Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. Fluids Barriers CNS. 2013;10(1):20doi: 10.1186/2045-8118-10-20.
Patton, S. M., Cho, Y. W., Clardy, T. W., Allen, R. P., Earley, C. J., & Connor, J. R. (2013). Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. Fluids and barriers of the CNS, 10(1), 20. https://doi.org/10.1186/2045-8118-10-20
Patton, Stephanie M, et al. "Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease." Fluids and barriers of the CNS vol. 10,1 (2013): 20. doi: https://doi.org/10.1186/2045-8118-10-20
Patton SM, Cho YW, Clardy TW, Allen RP, Earley CJ, Connor JR. Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. Fluids Barriers CNS. 2013 Jun 07;10(1):20. doi: 10.1186/2045-8118-10-20. PMID: 23758918; PMCID: PMC3680184.
Copy Download .nbib Format: NLM
Release and inhibitory effects of prostaglandin D2 in guinea pig urinary bladder and the role of urothelium.

Biochimica et biophysica acta

Guan NN, Nilsson KF, Wiklund PN, Gustafsson LE.
PMID: 25224734
Biochim Biophys Acta. 2014 Dec;1840(12):3443-51. doi: 10.1016/j.bbagen.2014.09.010. Epub 2014 Sep 16.

BACKGROUND: While studying a urothelium-derived inhibitory factor in guinea pig urinary bladders we observed considerable release of prostanoids, including PGD2-like activity. The present study was carried out to identify the prostanoids and to study their roles in modulating guinea...

Cite
Guan NN, Nilsson KF, Wiklund PN, et al. Release and inhibitory effects of prostaglandin D2 in guinea pig urinary bladder and the role of urothelium. Biochim Biophys Acta. 2014;1840(12):3443-51doi: 10.1016/j.bbagen.2014.09.010.
Guan, N. N., Nilsson, K. F., Wiklund, P. N., & Gustafsson, L. E. (2014). Release and inhibitory effects of prostaglandin D2 in guinea pig urinary bladder and the role of urothelium. Biochimica et biophysica acta, 1840(12), 3443-51. https://doi.org/10.1016/j.bbagen.2014.09.010
Guan, Na N, et al. "Release and inhibitory effects of prostaglandin D2 in guinea pig urinary bladder and the role of urothelium." Biochimica et biophysica acta vol. 1840,12 (2014): 3443-51. doi: https://doi.org/10.1016/j.bbagen.2014.09.010
Guan NN, Nilsson KF, Wiklund PN, Gustafsson LE. Release and inhibitory effects of prostaglandin D2 in guinea pig urinary bladder and the role of urothelium. Biochim Biophys Acta. 2014 Dec;1840(12):3443-51. doi: 10.1016/j.bbagen.2014.09.010. Epub 2014 Sep 16. PMID: 25224734.
Copy Download .nbib Format: NLM
HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells.

Vaccines

Marone G, Rossi FW, Pecoraro A, Pucino V, Criscuolo G, Paulis A, Spadaro G, Marone G, Varricchi G.
PMID: 32375243
Vaccines (Basel). 2020 May 03;8(2). doi: 10.3390/vaccines8020208.

Human lung mast cells (HLMCs) express the high-affinity receptor FcεRI for IgE and are involved in chronic pulmonary diseases occurring at high frequency among HIV-infected individuals. Immunoglobulin superantigens bind to the variable regions of either the heavy or light...

Cite
Marone G, Rossi FW, Pecoraro A, et al. HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells. Vaccines (Basel). 2020;8(2)doi: 10.3390/vaccines8020208.
Marone, G., Rossi, F. W., Pecoraro, A., Pucino, V., Criscuolo, G., Paulis, A., Spadaro, G., Marone, G., & Varricchi, G. (2020). HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells. Vaccines, 8(2), . https://doi.org/10.3390/vaccines8020208
Marone, Giancarlo, et al. "HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells." Vaccines vol. 8,2 (2020). doi: https://doi.org/10.3390/vaccines8020208
Marone G, Rossi FW, Pecoraro A, Pucino V, Criscuolo G, Paulis A, Spadaro G, Marone G, Varricchi G. HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells. Vaccines (Basel). 2020 May 03;8(2). doi: 10.3390/vaccines8020208. PMID: 32375243; PMCID: PMC7349869.
Copy Download .nbib Format: NLM
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.

Hepatology communications

Sala M, Gonzales D, Leste-Lasserre T, Dugot-Senant N, Paradis V, Di Tommaso S, Dupuy JW, Pitard V, Dourthe C, Sciarra A, Sempoux C, Ferrell LD, Clouston AD, Miller G, Yeh MM, Thung S, Gouw ASH, Quaglia A, Han J, Huan J, Fan C, Crawford J, Nakanuma Y, Harada K, le Bail B, Castain C, Frulio N, Trillaud H, Possenti L, Blanc JF, Chiche L, Laurent C, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F.
PMID: 32490318
Hepatol Commun. 2020 Apr 11;4(6):809-824. doi: 10.1002/hep4.1514. eCollection 2020 Jun.

Until recently, 10% of hepatocellular adenomas (HCAs) remained unclassified (UHCA). Among the UHCAs, the sonic hedgehog HCA (shHCA) was defined by focal deletions that fuse the promoter of Inhibin beta E chain with GLI1. Prostaglandin D2 synthase was proposed...

Cite
Sala M, Gonzales D, Leste-Lasserre T, et al. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatol Commun. 2020;4(6):809-824doi: 10.1002/hep4.1514.
Sala, M., Gonzales, D., Leste-Lasserre, T., Dugot-Senant, N., Paradis, V., Di Tommaso, S., Dupuy, J. W., Pitard, V., Dourthe, C., Sciarra, A., Sempoux, C., Ferrell, L. D., Clouston, A. D., Miller, G., Yeh, M. M., Thung, S., Gouw, A. S. H., Quaglia, A., Han, J., Huan, J., Fan, C., Crawford, J., Nakanuma, Y., Harada, K., le Bail, B., Castain, C., Frulio, N., Trillaud, H., Possenti, L., Blanc, J. F., Chiche, L., Laurent, C., Balabaud, C., Bioulac-Sage, P., Raymond, A. A., & Saltel, F. (2020). ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatology communications, 4(6), 809-824. https://doi.org/10.1002/hep4.1514
Sala, Margaux, et al. "ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice." Hepatology communications vol. 4,6 (2020): 809-824. doi: https://doi.org/10.1002/hep4.1514
Sala M, Gonzales D, Leste-Lasserre T, Dugot-Senant N, Paradis V, Di Tommaso S, Dupuy JW, Pitard V, Dourthe C, Sciarra A, Sempoux C, Ferrell LD, Clouston AD, Miller G, Yeh MM, Thung S, Gouw ASH, Quaglia A, Han J, Huan J, Fan C, Crawford J, Nakanuma Y, Harada K, le Bail B, Castain C, Frulio N, Trillaud H, Possenti L, Blanc JF, Chiche L, Laurent C, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatol Commun. 2020 Apr 11;4(6):809-824. doi: 10.1002/hep4.1514. eCollection 2020 Jun. PMID: 32490318; PMCID: PMC7262286.
Copy Download .nbib Format: NLM
Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis.

Cell metabolism

Wiley CD, Sharma R, Davis SS, Lopez-Dominguez JA, Mitchell KP, Wiley S, Alimirah F, Kim DE, Payne T, Rosko A, Aimontche E, Deshpande SM, Neri F, Kuehnemann C, Demaria M, Ramanathan A, Campisi J.
PMID: 33811820
Cell Metab. 2021 Jun 01;33(6):1124-1136.e5. doi: 10.1016/j.cmet.2021.03.008. Epub 2021 Apr 02.

Cellular senescence is a stress or damage response that causes a permanent proliferative arrest and secretion of numerous factors with potent biological activities. This senescence-associated secretory phenotype (SASP) has been characterized largely for secreted proteins that participate in embryogenesis,...

Cite
Wiley CD, Sharma R, Davis SS, et al. Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell Metab. 2021;33(6):1124-1136.e5doi: 10.1016/j.cmet.2021.03.008.
Wiley, C. D., Sharma, R., Davis, S. S., Lopez-Dominguez, J. A., Mitchell, K. P., Wiley, S., Alimirah, F., Kim, D. E., Payne, T., Rosko, A., Aimontche, E., Deshpande, S. M., Neri, F., Kuehnemann, C., Demaria, M., Ramanathan, A., & Campisi, J. (2021). Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell metabolism, 33(6), 1124-1136.e5. https://doi.org/10.1016/j.cmet.2021.03.008
Wiley, Christopher D, et al. "Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis." Cell metabolism vol. 33,6 (2021): 1124-1136.e5. doi: https://doi.org/10.1016/j.cmet.2021.03.008
Wiley CD, Sharma R, Davis SS, Lopez-Dominguez JA, Mitchell KP, Wiley S, Alimirah F, Kim DE, Payne T, Rosko A, Aimontche E, Deshpande SM, Neri F, Kuehnemann C, Demaria M, Ramanathan A, Campisi J. Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell Metab. 2021 Jun 01;33(6):1124-1136.e5. doi: 10.1016/j.cmet.2021.03.008. Epub 2021 Apr 02. PMID: 33811820; PMCID: PMC8501892.
Copy Download .nbib Format: NLM
Divergent PGD.

Prostaglandins & other lipid mediators

Butterfield JH, Singh RJ.
PMID: 34029712
Prostaglandins Other Lipid Mediat. 2021 Aug;155:106563. doi: 10.1016/j.prostaglandins.2021.106563. Epub 2021 May 21.

Aspirin-exacerbated respiratory disease and some cases of chronic idiopathic urticaria are disorders in which increased baseline urinary excretion of leukotriene(LT)E4 further increases following aspirin administration. Increased urinary excretion of the metabolites of prostaglandin D2, 11β-prostaglandin(PG)F2α and (2,3-dinor)-11β-PGF2α, have been...

Cite
Butterfield JH, Singh RJ. Divergent PGD. Prostaglandins Other Lipid Mediat. 2021;155:106563doi: 10.1016/j.prostaglandins.2021.106563.
Butterfield, J. H., & Singh, R. J. (2021). Divergent PGD. Prostaglandins & other lipid mediators, 155106563. https://doi.org/10.1016/j.prostaglandins.2021.106563
Butterfield, Joseph H, and Singh, Ravinder J. "Divergent PGD." Prostaglandins & other lipid mediators vol. 155 (2021): 106563. doi: https://doi.org/10.1016/j.prostaglandins.2021.106563
Butterfield JH, Singh RJ. Divergent PGD. Prostaglandins Other Lipid Mediat. 2021 Aug;155:106563. doi: 10.1016/j.prostaglandins.2021.106563. Epub 2021 May 21. PMID: 34029712.
Copy Download .nbib Format: NLM
Prostaglandin D.

The Korean journal of pain

Li Y, Kim WM, Kim SH, You HE, Kang DH, Lee HG, Choi JI, Yoon MH.
PMID: 33380565
Korean J Pain. 2021 Jan 01;34(1):27-34. doi: 10.3344/kjp.2021.34.1.27.

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a major reason for stopping or changing anticancer therapy. Among the proposed pathomechanisms underlying CIPN, proinflammatory processes have attracted increasing attention. Here we assessed the role of prostaglandin DMETHODS: CIPN was induced by...

Cite
Li Y, Kim WM, Kim SH, et al. Prostaglandin D. Korean J Pain. 2021;34(1):27-34doi: 10.3344/kjp.2021.34.1.27.
Li, Y., Kim, W. M., Kim, S. H., You, H. E., Kang, D. H., Lee, H. G., Choi, J. I., & Yoon, M. H. (2021). Prostaglandin D. The Korean journal of pain, 34(1), 27-34. https://doi.org/10.3344/kjp.2021.34.1.27
Li, Yaqun, et al. "Prostaglandin D." The Korean journal of pain vol. 34,1 (2021): 27-34. doi: https://doi.org/10.3344/kjp.2021.34.1.27
Li Y, Kim WM, Kim SH, You HE, Kang DH, Lee HG, Choi JI, Yoon MH. Prostaglandin D. Korean J Pain. 2021 Jan 01;34(1):27-34. doi: 10.3344/kjp.2021.34.1.27. PMID: 33380565; PMCID: PMC7783857.
Copy Download .nbib Format: NLM
The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?.

International archives of allergy and immunology

Sahiner UM, Arik Yilmaz E, Fontanella S, Haider S, Soyer O, Custovic A, Kalayci O, Sackesen C.
PMID: 34518469
Int Arch Allergy Immunol. 2021;182(12):1212-1221. doi: 10.1159/000517865. Epub 2021 Sep 09.

INTRODUCTION: Children with food allergy are at increased risk for asthma and asthma morbidity. Since leukotrienes are implicated in the pathogenesis of both asthma and probably in food allergies, we hypothesized that asthmatic children with concomitant food allergy may...

Cite
Sahiner UM, Arik Yilmaz E, Fontanella S, et al. The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?. Int Arch Allergy Immunol. 2021;182(12):1212-1221doi: 10.1159/000517865.
Sahiner, U. M., Arik Yilmaz, E., Fontanella, S., Haider, S., Soyer, O., Custovic, A., Kalayci, O., & Sackesen, C. (2021). The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?. International archives of allergy and immunology, 182(12), 1212-1221. https://doi.org/10.1159/000517865
Sahiner, Umit Murat, et al. "The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?." International archives of allergy and immunology vol. 182,12 (2021): 1212-1221. doi: https://doi.org/10.1159/000517865
Sahiner UM, Arik Yilmaz E, Fontanella S, Haider S, Soyer O, Custovic A, Kalayci O, Sackesen C. The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?. Int Arch Allergy Immunol. 2021;182(12):1212-1221. doi: 10.1159/000517865. Epub 2021 Sep 09. PMID: 34518469.
Copy Download .nbib Format: NLM
Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.

Cell death and differentiation

Hu S, Ren S, Cai Y, Liu J, Han Y, Zhao Y, Yang J, Zhou X, Wang X.
PMID: 34743203
Cell Death Differ. 2021 Nov 06; doi: 10.1038/s41418-021-00880-2. Epub 2021 Nov 06.

Glycoprotein prostaglandin D2 synthase (PTGDS) is a member of the lipocalin superfamily and plays dual roles in prostaglandins metabolism and lipid transport. PTGDS has been involved in various cellular processes including the tumorigenesis of solid tumors, yet its role...

Cite
Hu S, Ren S, Cai Y, et al. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. Cell Death Differ. 2021;doi: 10.1038/s41418-021-00880-2.
Hu, S., Ren, S., Cai, Y., Liu, J., Han, Y., Zhao, Y., Yang, J., Zhou, X., & Wang, X. (2021). Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. Cell death and differentiation, . https://doi.org/10.1038/s41418-021-00880-2
Hu, Shunfeng, et al. "Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling." Cell death and differentiation vol. (2021). doi: https://doi.org/10.1038/s41418-021-00880-2
Hu S, Ren S, Cai Y, Liu J, Han Y, Zhao Y, Yang J, Zhou X, Wang X. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. Cell Death Differ. 2021 Nov 06; doi: 10.1038/s41418-021-00880-2. Epub 2021 Nov 06. PMID: 34743203.
Copy Download .nbib Format: NLM
In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis.

Molecular human reproduction

Philibert P, Déjardin S, Pirot N, Pruvost A, Nguyen AL, Bernex F, Poulat F, Boizet-Bonhoure B.
PMID: 33851217
Mol Hum Reprod. 2021 May 08;27(5). doi: 10.1093/molehr/gaab029.

Adenomyosis is characterised by epithelial gland and mesenchymal stroma invasion of the uterine myometrium. Adenomyosis is an oestrogen-dependent gynaecological disease in which a number of factors, such as inflammatory molecules, prostaglandins (PGs), angiogenic factors, cell proliferation and extracellular matrix...

Cite
Philibert P, Déjardin S, Pirot N, et al. In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis. Mol Hum Reprod. 2021;27(5)doi: 10.1093/molehr/gaab029.
Philibert, P., Déjardin, S., Pirot, N., Pruvost, A., Nguyen, A. L., Bernex, F., Poulat, F., & Boizet-Bonhoure, B. (2021). In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis. Molecular human reproduction, 27(5), . https://doi.org/10.1093/molehr/gaab029
Philibert, Pascal, et al. "In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis." Molecular human reproduction vol. 27,5 (2021). doi: https://doi.org/10.1093/molehr/gaab029
Philibert P, Déjardin S, Pirot N, Pruvost A, Nguyen AL, Bernex F, Poulat F, Boizet-Bonhoure B. In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis. Mol Hum Reprod. 2021 May 08;27(5). doi: 10.1093/molehr/gaab029. PMID: 33851217.
Copy Download .nbib Format: NLM
Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters.

Clinical Medicine Insights. Cardiology

Vosper H.
PMID: 22084607
Clin Med Insights Cardiol. 2011;5:85-101. doi: 10.4137/CMC.S7601. Epub 2011 Sep 19.

The progression of atherosclerosis remains a major cause of morbidity and mortality. Plaque formation is an immunological response driven by a number of risk factors, and reduction of risk is the primary goal of treatment. The role of LDL-C...

Cite
Vosper H. Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters. Clin Med Insights Cardiol. 2011;5:85-101doi: 10.4137/CMC.S7601.
Vosper, H. (2011). Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters. Clinical Medicine Insights. Cardiology, 585-101. https://doi.org/10.4137/CMC.S7601
Vosper, Helen. "Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters." Clinical Medicine Insights. Cardiology vol. 5 (2011): 85-101. doi: https://doi.org/10.4137/CMC.S7601
Vosper H. Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters. Clin Med Insights Cardiol. 2011;5:85-101. doi: 10.4137/CMC.S7601. Epub 2011 Sep 19. PMID: 22084607; PMCID: PMC3201109.
Copy Download .nbib Format: NLM
Prostaglandin D2 synthase/prostaglandin D2/TWIST2 signaling inhibits breast cancer proliferation.

Anti-cancer drugs

Pan J, Zhang L, Huang J.
PMID: 34232948
Anticancer Drugs. 2021 Nov 01;32(10):1029-1037. doi: 10.1097/CAD.0000000000001111.

Though the past few years have witnessed exciting achievements in targeted and immunotherapeutic treatments of all breast cancer subtypes, yet the decline in breast cancer mortality has been slowed, urging the need for further expanding options of high-quality treatments....

Cite
Pan J, Zhang L, Huang J. Prostaglandin D2 synthase/prostaglandin D2/TWIST2 signaling inhibits breast cancer proliferation. Anticancer Drugs. 2021;32(10):1029-1037doi: 10.1097/CAD.0000000000001111.
Pan, J., Zhang, L., & Huang, J. (2021). Prostaglandin D2 synthase/prostaglandin D2/TWIST2 signaling inhibits breast cancer proliferation. Anti-cancer drugs, 32(10), 1029-1037. https://doi.org/10.1097/CAD.0000000000001111
Pan, Jun, et al. "Prostaglandin D2 synthase/prostaglandin D2/TWIST2 signaling inhibits breast cancer proliferation." Anti-cancer drugs vol. 32,10 (2021): 1029-1037. doi: https://doi.org/10.1097/CAD.0000000000001111
Pan J, Zhang L, Huang J. Prostaglandin D2 synthase/prostaglandin D2/TWIST2 signaling inhibits breast cancer proliferation. Anticancer Drugs. 2021 Nov 01;32(10):1029-1037. doi: 10.1097/CAD.0000000000001111. PMID: 34232948.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 90 entries